Clinical Trials

GastrointestinalGynecologicOther solid neoplasmThoracic

474 enrolled

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Mesothelioma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Colorectal Neoplasms

NCT06596473 2026-05-26

A Study of BG-C477 in Participants With Advanced Solid Tumors

310 enrolled

Advanced Solid Tumors

NCT07111546 2026-05-26

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

140 enrolled

Advanced Solid Tumour

NCT07128303 2026-05-26

Study of GS-5319 in Adults With Solid Tumors

178 enrolled

Advanced Solid Tumor

NCT07176975 2026-05-26

A Study to Test How Well Different Doses of BI 1831169 in Combination With an Anti-PD1 Antibody Are Tolerated in Japanese People With Different Advanced Cancers

46 enrolled

Solid Tumors

NCT07181681 2026-05-26

A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors

63 enrolled

Solid Tumors

NCT07446855 2026-05-26

PARTHENON

180 enrolled

Solid Tumours

NCT07606612 2026-05-26

A Study of SI-B036 in Patients With Locally Advanced or Metastatic Solid Tumors

31 enrolled

Solid Tumor

NCT07607054 2026-05-26

A First-in-human Phase I Study to Evaluate EMB-15 in Patients With Locally Advanced or Metastatic Solid Tumors.

50 enrolled

Locally Advanced or Metastatic Solid Tumors

NCT04381806 2026-05-22

Phase I Study in Advanced Malignancies With 5-ALA

Phase 1 Suspended

130 enrolled

Phase 1/2 Active not recruiting

Solid Tumor

NCT04826341 2026-05-22

A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer, Extra-Pulmonary Small Cell Neuroendocrine Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP Inhibitors

35 enrolled

Other solid neoplasmThoracic

HRD Cancer

NCT05277168 2026-05-22

A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS

83 enrolled

Advanced Solid Tumors

NCT05839600 2026-05-22

A Study to Find a Suitable Dose of BI 1821736 and Test Whether it Helps People With Advanced Cancer

Phase 1 Terminated

10 enrolled 12 charts

Solid Tumors

NCT05981703 2026-05-22

A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors

217 enrolled

Advanced Solid Tumor

NCT06115642 2026-05-22

A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX43 in Advanced/Metastatic Solid Tumors

367 enrolled

Advanced/Metastatic Malignant Solid Tumors

NCT06438588 2026-05-22

Fasting Mimicking Diet for Reducing Immune Related Adverse Events for Cancer Patients on Immune Checkpoint Inhibitors, FMD-ICI Trial

Phase NA Recruiting

10 enrolled

Advanced Malignant Solid Neoplasm

NCT06589596 2026-05-22

An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors

525 enrolled

Advanced Solid Tumor

NCT06598800 2026-05-22

Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors

153 enrolled

Advanced Solid Tumor

NCT06656390 2026-05-22

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors

202 enrolled

Advanced Cancer

NCT06679634 2026-05-22

Retinoblastoma Phase II Expanded Access Clinical Trial

30 enrolled

Phase NA Not yet recruiting

Retinoblastoma

NCT06771739 2026-05-22

A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial

20 enrolled

Malignant Solid Neoplasm

NCT06977737 2026-05-22

ATTEST

72 enrolled

Solid Tumor, Adult

NCT07192432 2026-05-22

SENTRY-HER2

27 enrolled

HER2 Expressing Solid Tumors

NCT07196644 2026-05-22

A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan

100 enrolled

Solid Tumors Harboring MET Amplification

NCT07205718 2026-05-22

A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors

223 enrolled

Advanced or Metastatic Solid Tumors

NCT07601243 2026-05-22

Study of GS-2426 in Participants With Advanced Solid Tumors

174 enrolled

Advanced Solid Tumors

NCT07601334 2026-05-22

Safety and Activity of HF50 in Patients With Advanced Solid Tumors

45 enrolled

Phase 1/2 Not yet recruiting

Advanced Solid Tumors

NCT07602855 2026-05-22

A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)

184 enrolled

Phase 2 Not yet recruiting

Solid Tumors

NCT07602946 2026-05-22

SELECTmeso

30 enrolled

Other solid neoplasmThoracic

Mesothelioma

NCT05155332 2026-05-20

A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)

Phase 1 Suspended

190 enrolled

Solid Tumors

NCT06006273 2026-05-20

A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors

48 enrolled

Refractory Solid Tumors

NCT06573294 2026-05-20

Trial to Assess the Safety and Antitumor Activity of GEN1057 in Malignant Solid Tumors

Phase 1 Terminated

23 enrolled

Advanced Malignant Solid Tumors

NCT06598371 2026-05-20

A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors

141 enrolled

Select Advanced Solid Tumors

NCT07207707 2026-05-20

A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies

78 enrolled

Other solid neoplasmThoracic

Solid Tumor Malignancies

NCT04158141 2026-05-19

Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma

Phase 3 Terminated

16 enrolled 18 charts

Mesothelioma, Malignant, Mesothelioma

NCT06265688 2026-05-19

First In Human Study of CX-2051 in Advanced Solid Tumors

160 enrolled

Solid Tumor, Adult

NCT06503146 2026-05-19

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

CNSEndocrineGastrointestinalGenitourinaryGynecologicOther solid neoplasmSarcomaThoracic

320 enrolled

Urinary Bladder Neoplasms, Carcinoma, Hepatocellular, Mesothelioma, Ovarian Neoplasms, Paraganglioma, Pheochromocytoma, Sarcoma, Stomach Neoplasms, Cholangiocarcinoma, Small Cell Lung Carcinoma

NCT07467629 2026-05-19

QLS5212 for Participants With Advanced Solid Tumors

100 enrolled